# US 2003/0077597 A1 · Novel germinal center kinase proteins, compositions and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0077597 A1
- Document ID: US20030077597A1
- Status: Published application
- Kind: A1
- Application number: 10/029,115
- Filed: 2001-10-19
- Published: 2003-04-24
- Earliest claimed: 2001-10-19
- Assignees: Rigel Pharmaceuticals, Inc.
- Inventors: Ying Luo; C. Alan Fu; Mary Shen
- Web page: https://patentgrep.com/patent/US20030077597A1

## CPC

- C12N 9/1205: {Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases}
- C12Q 1/485: {involving kinase}
- G01N 33/5041: {involving analysis of members of signalling pathways}
- G01N 2500/02: Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides compositions and methods for modulating cell proliferation, survival, morphology, and migration. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating proliferation, survival, morphology and migration in mammalian cells are provided. Compositions and methods for the treatment of disorders related to cell proliferation, survival, morphology and migration are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating proliferation, survival, morphology and migration in mammalian cells.

## Claims

### Claim 1

A recombinant nucleic acid, capable of hybridizing to a nucleic acid comprising a nucleic acid sequence selected from the group consisting of the nucleic acid sequences set forth in SEQ ID NOs: 1, 3, and 5, or complements thereof.

### Claim 2

A recombinant nucleic acid, comprising a nucleic acid sequence having at least about 90% identity to a nucleic acid sequence selected from the group consisting of the nucleic acid sequences set forth in SEQ ID NOs: 1, 3, and 5 or complements thereof.

### Claim 3

A recombinant nucleic acid according to claim I or 2, wherein said nucleic acid comprises a nucleic acid sequence selected from the group consisting of the nucleic acid sequences set forth in SEQ ID NOs: 1, 3, and 5 or complements thereof.

### Claim 4

A recombinant polypeptide, comprising an amino acid sequence having at least about 95% identity to an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOs: 2, 4, and 6.

### Claim 5 (depends on 4)

A recombinant polypeptide according to claim 4, further comprising an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOs: 2, 4, and 6.

### Claim 6 (depends on 2)

A recombinant polypeptide, comprising an amino acid sequence which is encoded by the nucleic acid of claim 2.

### Claim 7

A method for screening for a candidate bioactive agent capable of modulating phosphorylation of JNK, comprising
i) contacting a candidate bioactive agent to a mammalian cell comprising a recombinant MINK3 nucleic acid encoding a MINK3 protein and a JNK protein; and
ii) determining the phosphorylation of said JNK protein in the presence of candidate agent; wherein said recombinant MINK3 nucleic acid is expressed in said mammalian cell, wherein said encoded MINK3 protein comprises an amino acid sequence having at least about 90% identity to an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOs: 2, 4 and 6, wherein said encoded MINK3 protein will phosphorylate said JNK protein in the absence of said candidate bioactive agent, and wherein a decrease in the phosphorylation of said JNK protein in the presence of said candidate bioactive agent indicates that said candidate bioactive agent is capable of modulating phosphorylation of JNK.

### Claim 8

A method for screening for a candidate bioactive agent capable of modulating mammalian ERK phosphorylation, comprising:
i) contacting a candidate bioactive agent to a mammalian cell comprising a recombinant MINK3 nucleic acid encoding a MINK3 protein and an ERK protein; and
ii) determining the phosphorylation of said ERK protein in the presence of candidate agent; wherein said recombinant MINK3 nucleic acid is expressed in said mammalian cell, wherein said encoded MINK3 protein comprises an amino acid sequence having at least about 90% identity to an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOs: 2, 4 and 6, wherein said encoded MINK3 protein will phosphorylate said ERK protein in the absence of said candidate bioactive agent, and wherein a decrease in the phosphorylation of said ERK protein in the presence of said candidate bioactive agent indicates that said candidate bioactive agent is capable of modulating phosphorylation of ERK.

### Claim 9

A method for screening for a candidate bioactive agent capable of modulating mammalian JNK activity, comprising:
i) contacting a candidate bioactive agent to a mammalian cell comprising a recombinant MINK3 nucleic acid encoding a MINK3 protein and an JNK protein; and
ii) determining the activity of said JNK protein in the presence of candidate agent; wherein said recombinant MINK3 nucleic acid is expressed in said mammalian cell, wherein said encoded MINK3 protein comprises an amino acid sequence having at least about 90% identity to an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOs: 2, 4 and 6, wherein said encoded MINK3 protein will activate said JNK protein in the absence of said candidate bioactive agent, and wherein a decrease in the activity of said JNK protein in the presence of said candidate bioactive agent indicates that said candidate bioactive agent is capable of modulating JNK activity.

### Claim 10

A method for screening for a candidate bioactive agent capable of modulating mammalian ERK activity, comprising:
i) contacting a candidate bioactive agent to a mammalian cell comprising a recombinant MINK3 nucleic acid encoding a MINK3 protein and an ERK protein; and
ii) determining the activity of said ERK protein in the presence of candidate agent; wherein said recombinant MINK3 nucleic acid is expressed in said mammalian cell, wherein said encoded MINK3 protein comprises an amino acid sequence having at least about 90% identity to an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOs: 2, 4 and 6, wherein said encoded MINK3 protein will activate said ERK protein in the absence of said candidate bioactive agent, and wherein a decrease in the activity of said ERK protein in the presence of said candidate bioactive agent indicates that said candidate bioactive agent is capable of modulating ERK activity.

### Claim 11

A method for screening for a candidate bioactive agent capable of modulating proliferation in a mammalian cell, comprising:
a) contacting a candidate bioactive agent to a mammalian cell comprising a recombinant MINK3 nucleic acid encoding a MINK3 protein; and
b) determining the effect on the cell in the presence and absence of said candidate bioactive agent;
wherein said recombinant MINK3 nucleic acid is expressed in said mammalian cell, and wherein said encoded MINK3 protein comprises an amino acid sequence having at least about 90% identity to an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOs: 2, 4 and 6.

### Claim 12

A method for screening for a candidate bioactive agent capable of modulating growth factor induced-ERK activation in a mammalian cell, comprising:
a) contacting a candidate bioactive agent to a mammalian cell comprising a recombinant MINK3 nucleic acid encoding a MINK3 protein; and
b) determining ERK activity in the presence and absence of said candidate bioactive agent;
wherein said recombinant MINK3 nucleic acid is expressed in said mammalian cell, and wherein said encoded MINK3 protein comprises an amino acid sequence having at least about 90% identity to an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOs: 2, 4 and 6.

### Claim 13

A method for diagnosing a mammalian cell proliferation disorder, comprising sequencing at least a portion of at least one MINK3 gene encoding a gene transcript comprising a nucleic acid sequence selected from the group consisting of the nucleic acid sequences set forth in SEQ ID NOs: 1, 3, and 5 and determining the sequence of said MINK3 gene or a portion thereof.

### Claim 14

A medicament for the treatment of a mammalian cell proliferation disorder, comprising a MINK3 antisense nucleic acid comprising a nucleic acid sequence complementary the nucleic acid sequence set forth by nucleotides 2804-3187 in SEQ ID NO: 1.

### Claim 15

A method for screening for a candidate agent capable of modulating cell survival, comprising:
a) contacting a candidate bioactive agent to a mammalian cell comprising a recombinant MINK3 nucleic acid encoding a MINK3 protein; and
b) determining the ratio of the amount of cleaved Rb to the amount of native Rb in the presence and absence of candidate agent;
wherein said recombinant MINK3 nucleic acid is expressed in said mammalian cell, and wherein said encoded MINK3 protein comprises an amino acid sequence having at least about 90% identity to an amino acid sequence selected from the group consisting of the amino acid sequences set forth in SEQ ID NOs: 2, 4 and 6.
